Novartis Ag (NVS) Shares Issued (2019 - 2025)
Novartis Ag's (NVS) quarterly Shares Issued came in at $4.0 million in Q4 2025, down 84.0% year-on-year from $25.0 million in Q4 2024, and up 100.0% quarter-over-quarter from $2.0 million in Q3 2025.
Novartis Ag (NVS) Shares Issued (2019 - 2025) Analysis & Trends
Novartis Ag has disclosed Shares Issued across 7 years of filings, most recently posting $4.0 million for Q4 2025.
- Shares Issued for Q4 2025 came in at $4.0 million, down 84.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $27.0 million (down 46.0% YoY), and the FY2025 annual result was $27.0 million, down 10.0% from the prior year.
- Shares Issued came in at $4.0 million for Q4 2025 at Novartis Ag, up from $2.0 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $159.0 million in Q1 2023 to a low of -$5.0 million in Q4 2023.
- The 5-year median for Shares Issued is $13.0 million (2022), against an average of $27.7 million.
- Across the five-year window, Shares Issued tumbled 96.32% in 2021 and surged 600.0% in 2024, its largest moves.
- Novartis Ag's Shares Issued stood at $23.0 million in 2021, then slumped by 73.91% to $6.0 million in 2022, then tumbled by 183.33% to -$5.0 million in 2023, then soared by 600.0% to $25.0 million in 2024, then tumbled by 84.0% to $4.0 million in 2025.
- The last three Shares Issued figures came in at $4.0 million (Q4 2025), $2.0 million (Q3 2025), and $20.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | 10.79 Mn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 1.17 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | - |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | 157.00 Mn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 166.00 Mn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | - |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.00 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 20.00 Mn |
| Jun 30, 2025 | 20.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 25.00 Mn |
| Dec 31, 2024 | 25.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 25.00 Mn |
| Jun 30, 2024 | 25.00 Mn |
| Dec 31, 2023 | -5.00 Mn |
| Dec 31, 2023 | -5.00 Mn |
| Sep 30, 2023 | -1.00 Mn |
| Sep 30, 2023 | -1.00 Mn |
| Mar 31, 2023 | 159.00 Mn |
| Mar 31, 2023 | 159.00 Mn |